Avalo Therapeutics Inc. Made Headway

Wed, Jun 07, 2023 at 07:53 PM

Avalo Therapeutics Inc. (AVTX:NASDAQ) rocketted at $3.89, a gain of 28.8%. On Wed, Jun 07, 2023, AVTX:NASDAQ touched a New 2-Week High of $3.89. The stock appeared on our News Catalysts scanner on Thu, Jun 01, 2023 at 08:29 AM in the 'MISCELLANEOUS' category. From Wed, May 24, 2023, the stock recorded 44.44% Up Days and 40.00% Green Days

About Avalo Therapeutics Inc. (AVTX:NASDAQ)

Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in...

Top 10 Gainers:

MGO Global Inc. (MGOL:NASDAQ), 84.8%
Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ), 79.59%
Farmer Bros. Co. (FARM:NASDAQ), 70.47%
Scopus BioPharma Inc. (SCPS:NASDAQ), 54.3%
Yext, Inc. (YEXT:NYSE), 38.44%
Leafly Holdings Inc. (LFLY:NASDAQ), 33.17%
SRAX, Inc. (SRAX:NASDAQ), 31.29%
Panbela Therapeutics Inc. (PBLA:NASDAQ), 29.17%
Avalo Therapeutics Inc. (AVTX:NASDAQ), 28.81%
Stitch Fix, Inc. (SFIX:NASDAQ), 27.99%